Li, Yafeng
Zou, Zichun
Yi, Peng
Xu, Chen
Tian, Zhifeng
Zhang, Xi
Zhang, Jing
Funding for this research was provided by:
Tianjin Applied Basic Research Multiple Investment Fund (21JCYBJC01400)
Article History
Received: 6 May 2023
Accepted: 4 June 2024
First Online: 15 July 2024
Declarations
:
: The study was approved by Tianjin Hospital Clinical Trial Ethics Committee with the approval number SL20180047.
: Authors state no conflict of interest.